The Coronary Artery Risk Development in Young Adults (CADIA)
study of young overweight adults, black and white, demonstrated that dietary
patterns characterised by increased dairy consumption had an inverse
association with insulin resistance in their study population. The inclusion of
low or non-fat dairy products, which provide additional calcium in the diet,
may promote increased weight loss and improve insulin resistance. Therefore,
supplementing dairy products to obese subjects on a caloric-restricted diet may
be a useful strategy to enhance weight loss and improve insulin resistance. The
study assesses dairy Calcium supplementation and its effects on body Fat,
plasma leptin and glucose levels in obese postmenopausal women. This
prospective randomised study of 3 months, parallel trial on the effect of
non-fat / low-fat dairy calcium combined with energy restriction in
overweight/obese postmenopausal women. The study therefore tested the
short-term effects of supplementing 56 overweight or obese (body mass index
[BMI] >26 kg/m2) post menopausal women on a caloric-restricted diet (1,400
kilocalories [kcal]) with two levels of dairy as yoghurt on body composition,
blood insulin, leptin and glucose concentration. The group consuming four
supplemented dairy servings (DS-4) was provided ~1400 mg Ca/day, and the group
consuming two supplemented dairy servings (DS-2) were provided ~800 mg Ca/day.
Over the 3-months daily energy intake averaged 51%
carbohydrate, 20.7% of protein and 27.6% of fat for both groups. At 3 months,
the DS-4 group demonstrated decreased weight (87.7 to 86.2 kg, P=0.001), BMI
(33.5 to 32.8 kg/m2, P < 0.001), total fat (36.1 to 34.7 kg, P<0.001),
and trunk fat (18.3 to 17.6 kg, P < 0.001). There were non-significant
decreases in plasma glucose (74.7 to 71.1 mg/dl, P=0.494), leptin (32.5 to 31.3
µg/L, P=0.231) and insulin. For the DS-2 group, there was decreased weight
(86.4 to 84.4 kg, p<0.02), BMI (32.5 to 31.8 kg/m2, P=0.002), total fat
(37.3 to 35.4 kg, P=0.003), trunk fat (17.1 to 16.5 kg, P = 0.27) and plasma
leptin (27.8 to 25.2 µg/L, P=0.114). The DS-2 group demonstrated a surprising
and significant increase in the fasting blood glucose, with a marginally
significant increase in insulin resistance as measured by HOMA at 3 months. We
observed a significant treatment effect between the DS-2 and DS-4 groups for: %
energy from fat (P=0.025), % energy from protein (P=0.047) and leptin
(P=0.044). The study report that in a population of obese/overweight
postmenopausal women supplementing their diet with dairy which provided a total
estimated calcium intake of ~1400 mg/day (i.e. DS-4) was successful in the
reduction of trunk fat and plasma glucose, while dairy calcium and caloric
restriction decreased weight, BMI, total body fat, and insulin and leptin
during the intervention. In contrast, the supplemented group ingesting 800 mg/d
of dairy calcium (i.e. DS-2) in combination with caloric restriction provided
significant increases in plasma glucose and insulin resistance.
Our study demonstrated the expected weight loss with caloric
restriction, but a paradoxical increase in blood glucose levels with dairy
supplementation provided to maintain baseline calcium intake. Increasing dairy
supplementation abrogated this small increase in fasting blood glucose and
insulin resistance. The benefits of dairy calcium supplementation may be
dependent on both the dose and the context of overall caloric intake.
Author(s) Details
Dina H. Fakhrawi
Department of Nutritional Sciences, University of Connecticut, Storrs, CT,
USA.
Carol J. Lammi-Keefe
Department of Nutritional Sciences, University of Connecticut, Storrs, CT,
USA and College of Agriculture, LSU, Agricultural Center, and Pennington
Biomedical Research Center, Louisiana State University, Baton Rouge, LA, USA.
W. Lawrence Beeson
School of Public Health, Loma Linda University, Loma Linda, CA, USA and
Center for Health Disparities and Molecular Medicine, School of Medicine, Loma
Linda University, USA.
T. Allan Darnell
School of Public Health, Loma Linda University, Loma Linda, CA, USA.
Anthony Firek
J L Pettis Memorial VA Medical Center, Endocrinology, Loma Linda, CA, USA.
Zaida R.
Cordero-MacIntyre
School of Public Health, Loma Linda University, Loma Linda, CA, USA, Center
for Health Disparities and Molecular Medicine, School of Medicine, Loma Linda
University, USA and Whittier College, Department of Kinesiology and Nutrition,
Whittier, CA, USA.
Please see the book here :- https://doi.org/10.9734/bpi/fsarh/v6/7123